Scarica l'app Stockscreener
3.40
0.58%
-0.02
Mdxhealth Sa Borsa (MDXH) Ultime notizie
MDxHealth to Release Q4 and Full Year 2025 Financial Results on February 26, 2026, Followed by Conference Call - Quiver Quantitative
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - The Manila Times
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewswire Inc.
Bond Watch: Whats the RSI of MDxHealth SA stock2025 Top Gainers & Expert-Curated Trade Recommendations - baoquankhu1.vn
Can MDxHealth SA stock continue upward trendWeekly Loss Report & Stock Portfolio Risk Management - mfd.ru
MDxHealth Details Exosome Diagnostics Deal and Restructured GPS Earnout Obligations - TipRanks
Will MDxHealth SA stock benefit from infrastructure spendingGold Moves & Low Risk Growth Stock Ideas - mfd.ru
Trading Action: Should I invest in MDxHealth SA before earningsJuly 2025 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Shorts: Can Xcel Energy Inc disrupt its industryTrend Reversal & Real-Time Stock Entry Alerts - baoquankhu1.vn
Trend Recap: Whats the RSI of MDxHealth SA stockGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long - Sahm
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - MarketBeat
Retail Surge: How interest rate cuts could boost MDxHealth SA stockSwing Trade & Community Trade Idea Sharing Platform - Bộ Nội Vụ
MDxHealth Posts Preliminary 2025 Results, Expects Revenue Growth Of 26% To 28% In 2026 - Nasdaq
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance By Investing.com - Investing.com India
MDxHealth Sees Over 20% Revenue Growth in Q4, Full Year - Orange County Business Journal
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance - Investing.com
MDXH Projects Strong Revenue Growth and Ambitious 2026 Targets - GuruFocus
MDxHealth sees Q4 revenue $30.5M, consensus $26.18M - TipRanks
MDxHealth Posts Strong 2025 Revenue Growth, Sets 2026 Outlook and Revises Exact Sciences Earnout - TipRanks
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences - The Manila Times
Redlands Daily Facts - FinancialContent
MDxHealth (NASDAQ:MDXH) and Biotricity (OTCMKTS:BTCY) Critical Survey - Defense World
How MDxHealth SA stock reacts to job market data2025 Geopolitical Influence & Technical Entry and Exit Tips - ulpravda.ru
Will MDxHealth SA stock attract ESG investors2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Analyst Downgrade: How MDxHealth SA stock reacts to inflationary pressures2025 Pullback Review & High Yield Equity Trading Tips - Улправда
Is MDxHealth SA stock dividend yield sustainableWeekly Market Report & Consistent Income Trade Ideas - Улправда
How MDxHealth SA stock reacts to inflationary pressuresTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда
Can MDxHealth SA stock resist sector downturnsJuly 2025 Fed Impact & Capital Protection Trade Alerts - Улправда
MDxHealth announces next phase of collab with University of Oxford - MSN
Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term - Yahoo Finance
MDxHealth SAOrdinary Shares (NQ: MDXH - FinancialContent
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - The Manila Times
World’s largest prostate cancer trial adds genomic test to guide care - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
MDxHealth Files to Sell Up to $200 Million in Shares - marketscreener.com
MDxHealth SA to offer securities up to $200 millionSEC filing - marketscreener.com
Setup Watch: Will MDxHealth SA stock continue dividend increasesWeekly Trend Recap & Expert Verified Movement Alerts - Bộ Nội Vụ
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
MDXH: BTIG Reiterates Buy Rating with $7 Price Target | MDXH Sto - GuruFocus
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target By Investing.com - Investing.com South Africa
BTIG Research Reaffirms "Buy" Rating for MDxHealth (NASDAQ:MDXH) - MarketBeat
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target - Investing.com Australia
How MDxHealth SA stock benefits from tech adoptionMarket Sentiment Review & Capital Efficient Trading Techniques - Улправда
Why MDxHealth SA stock remains undervalued2025 Valuation Update & Weekly Watchlist for Consistent Profits - Улправда
0.00%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):